Literature DB >> 35687567

Development of protective equipment for endoscopic treatment and surgery in otorhinolaryngology.

Yoshinori Matsuwaki1, Daiki Ariyoshi2, Risa Iwamoto2, Tetsuya Morishima2, Keita Kimura2, Daisuke Kikuchi3.   

Abstract

OBJECTIVE: The coronavirus disease pandemic has raised concerns regarding the transmission of infections to healthcare workers. We developed a new protective device to reduce the risk of aerosol diffusion and droplet infection among healthcare workers. Here, we report the results of a theoretical evaluation of the efficacy of this device.
METHODS: We used suction-capable masks with and without rubber slits, sleeves for the insertion section of endoscopes and treatment tools, and a cover for the control section of the endoscope. To simulate droplet spread from patients, we created a droplet simulation model and an aerosol simulation model. The results with and without the devices attached and with and without the suction were compared.
RESULTS: The droplet simulation model showed a 95% reduction in droplets with masks with rubber slits; furthermore, a reduction of 100% was observed when the insertion sleeve was used. Evaluation of aerosol simulation when suction was applied revealed an aerosol reduction of 98% and >99% with the use of the mask without rubber slits and with the combined use of the mask and insertion sleeve, respectively. The elimination of droplet emission upon instrument removal confirmed that the instrument sleeve prevented the diffusion of droplets. The elimination of droplets upon repeated pressing of the suction button confirmed that the cover prevented the diffusion of droplets.
CONCLUSION: We developed a device for infection control, in collaboration with a gastrointestinal endoscopist and Olympus Medical Systems Corporation, that was effective in reducing droplet and aerosol diffusion in this initial theoretical assessment.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35687567      PMCID: PMC9187069          DOI: 10.1371/journal.pone.0268974

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

The global outbreak of the new coronavirus disease 2019 (COVID-19) has raised concerns regarding the number of patient deaths and transmission of infection to healthcare workers. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has been detected at the highest concentrations in sputum and upper respiratory tract secretions [1, 2]. In addition, the virus can be transmitted by and remains infectious even in small droplets [3]. Virus-containing droplets vary in size, with larger droplets (>60 μm in diameter) tending to fall on surfaces closer to the patient (<2 m) and smaller droplets (10–60 μm in diameter) tending to fall on more distant surfaces [4]. It is known that aerosolized droplets with a diameter of <5 μm can become airborne [5, 6]. Many studies have shown that the virus can be detected in the air after infected patients cough, sneeze, or exhale in indoor environments [7, 8]; therefore, the risk of infection to healthcare workers is high. In particular, aerosol-generating treatment procedures are thought to increase the risk of infection to healthcare workers [1, 2]. It is known that the possibility of inhaling viruses in respiratory droplets is very high at a distance of a few meters, as is the case in examination and operating rooms [3]. In fact, there is much evidence that aerosols and droplets are generated during outpatient care, surgical care, and procedures in otorhinolaryngology [2, 9–12]. The risk of infection by such aerosols and droplets is not limited to otorhinolaryngology but is also a concern in other fields, such as gastrointestinal endoscopy [13-16], and personal protective equipment (PPE) for infection prevention is becoming increasingly important for healthcare workers. We have developed a new infection control device for use in outpatient otorhinolaryngology and surgery clinics in collaboration with a gastrointestinal endoscopist and Olympus Medical Systems Corporation. In this report, we describe the use of this infection control device and its effectiveness in reducing the spread of droplets and aerosols.

Materials and methods

Device

We developed the following items: a mask to be worn by the patient, an insertion sleeve to be placed over the insertion section of the endoscope, an instrument sleeve to be placed over the instrument, and a control section cover to be placed over the control section of the endoscope (Fig 1). The mask has four ports on its sides that allow air inflow and suction of aerosols and droplets generated by the patient. The ports can be equipped with a cap that can change the direction of air inflow, and a connector that can be connected to a suction tube. An endoscope insertion port is located in front of the mask, and this can be connected to the insertion sleeve with a joint. We developed two types of masks: one for outpatient use that contains a rubber slit at the endoscope insertion port to prevent splashes caused by coughing (Fig 1A), and one for surgical use with an open endoscope insertion port so that operability is not affected even when multiple instruments, such as a rigid endoscope and operative tools, are inserted (Fig 1B). These masks can also be worn over the nasal cannula and intubation tube. The insertion sleeve can cover the insertion section of the endoscope and can be attached to both rigid and flexible endoscopes. The insertion sleeve consists of a part that covers the insertion section of the endoscope and a joint that can be connected to the mask and it is used by fixing it at the root after inserting the endoscope insertion section (Fig 1C). The instrument sleeve has a part that covers the instrument and can be fixed near the handle of the instrument after insertion. The instrument can be inserted into the instrument channel with the sleeve attached, and one end of the instrument sleeve is fixed with a hook and loop fastener to the endoscope (Fig 1D). The control section cover is used to cover the control section of the endoscope. It has a hole for the hand of the endoscope operator, the universal cord of the endoscope, and the insertion section of the endoscope, and is used by fixing it with a hook and loop fastener after covering the control section (Fig 1E). An example of the mask and insertion sleeve on the head model is shown in Fig 1F.
Fig 1

Images of the prototype product.

(A) A mask with a rubber slit (for outpatient use). (B) A mask without a rubber slit (for surgery). (C) Insertion sleeve (attached to a flexible endoscope [Olympus ENF-VT3; Olympus Medical Systems Corporation, Tokyo, Japan] and a rigid endoscope [WA4KA400; Olympus Medical Systems Corporation, Tokyo, Japan]). (D) Instrument sleeve. (E) Control section cover. (F) An example of how the mask and insertion sleeve are attached to the head model when using a flexible endoscope for observation (OLYMPUS ENF-VH2; Olympus Medical Systems Corporation, Tokyo, Japan). A suction tube can be connected to the suction port of the mask. The endoscope insertion port of the mask and the insertion sleeve can be connected by a joint.

Images of the prototype product.

(A) A mask with a rubber slit (for outpatient use). (B) A mask without a rubber slit (for surgery). (C) Insertion sleeve (attached to a flexible endoscope [Olympus ENF-VT3; Olympus Medical Systems Corporation, Tokyo, Japan] and a rigid endoscope [WA4KA400; Olympus Medical Systems Corporation, Tokyo, Japan]). (D) Instrument sleeve. (E) Control section cover. (F) An example of how the mask and insertion sleeve are attached to the head model when using a flexible endoscope for observation (OLYMPUS ENF-VH2; Olympus Medical Systems Corporation, Tokyo, Japan). A suction tube can be connected to the suction port of the mask. The endoscope insertion port of the mask and the insertion sleeve can be connected by a joint.

Device use

The procedure for use of the device during outpatient care and surgery, respectively, is as follows. First, during outpatient examinations, the insertion sleeve is affixed to the endoscope and fixed at the root. The patient puts on the mask. A suction tube is attached to the port of the mask. The joint of the insertion sleeve is connected to the endoscope insertion port of the mask. The endoscopist then manipulates the endoscope through the insertion sleeve (Fig 2A). When the endoscopic operation is completed, the endoscope is stored inside the insertion sleeve, and the insertion sleeve is removed from the mask.
Fig 2

Device usage in outpatient and surgical settings.

(A) Usage in outpatient care: a mask (for outpatient use) is attached to the head model, an insertion sleeve is attached to the endoscope, the joint of the insertion sleeve is joined to the mask, and the surgeon is examining the patient. (i) Illustration of the procedure. (ii) Image showing how the device is used. (B) Usage in the operating room (for surgery): a mask connected to a suction unit is attached to the head model, and the surgeon is performing the treatment. (i) Illustration of the procedure. (ii) Image showing how the device is used. The individual in this figure has given written informed consent (as outlined in PLOS consent form) to publish these case details.

Device usage in outpatient and surgical settings.

(A) Usage in outpatient care: a mask (for outpatient use) is attached to the head model, an insertion sleeve is attached to the endoscope, the joint of the insertion sleeve is joined to the mask, and the surgeon is examining the patient. (i) Illustration of the procedure. (ii) Image showing how the device is used. (B) Usage in the operating room (for surgery): a mask connected to a suction unit is attached to the head model, and the surgeon is performing the treatment. (i) Illustration of the procedure. (ii) Image showing how the device is used. The individual in this figure has given written informed consent (as outlined in PLOS consent form) to publish these case details. When using a treatment instrument with a treatment endoscope, the instrument sleeve is attached to the instrument to be used beforehand and affixed to the endoscope. The control section cover is used to cover the control section of the endoscope. One end of the instrument sleeve is fixed to the endoscope, the instrument is inserted into the instrument channel, and the procedure is then performed. When the procedure is completed, the instrument is stored inside the instrument sleeve, which is then removed from the endoscope. During surgery, the patient wears a mask without a rubber slit, and a suction tube is attached to the suction port of the mask. The surgeon inserts the operative tools through the insertion port in front of the mask and performs the procedure as usual (Fig 2B).

Experiments

Evaluation of the reduction of droplets and aerosols dispersed from patient model

We created models that simulated droplets and aerosols dispersed from patients and evaluated the reduction of droplets and aerosols among the different device configurations. The device configurations common between the droplet and aerosol simulation models are as follows: Control (no device attached); No. 1: wearing a mask without a rubber slit (for surgery) without suction; No. 2: wearing a mask without a rubber slit (for surgery) with suction; No. 3: wearing a mask with a rubber slit (for outpatients) without suction; No. 4: wearing a mask with a rubber slit (for outpatients) with suction; No. 5: wearing a mask with a rubber slit (for outpatients) and using an endoscope (OLYMPUS ENF-VH2; Olympus Medical Systems Corporation, Tokyo, Japan) with an insertion sleeve without suction; and No. 6: wearing a mask with a rubber slit (for outpatients) and using an endoscope (OLYMPUS ENF-VH2; Olympus Medical Systems Corporation, Tokyo, Japan) with an insertion sleeve with suction.

Droplet simulation model

The droplets dispersed from patients’ oral and nasal cavities were simulated with black ink. In a test simulating sneezing, it was reported that droplets were scattered to a distance of 66 cm [11]; thus, we created a model that could simulate the same flight distance. A sheet of paper was placed 10 cm in front of a sprayer installed in the mouth of a Styrofoam model head, and 0.2 mL of black ink was sprayed. The inked paper was scanned and imaged. The brightness value of each pixel was binarized at a threshold value at which the background and the attached ink could be separated, and each pixel was divided into black and white. The number of black pixels was measured five times under the same conditions, and the average number of black pixels was compared with different device conditions. For the devices with suction, suction was applied from the suction port at a pressure of -40 kPa and a flow rate of 40 L/min (Fig 3A).
Fig 3

Simulated droplet and aerosol replication models.

(A) A sprayer was installed in the mouth of the head model (yellow arrow) and ink was sprayed. The paper onto which the ink was sprayed was imaged, and the number of pixels that became black after binarization was measured. (B) The airway management training model was placed inside the plastic case and the smoke from an e-cigarette was sprayed through a tube from outside the plastic case (yellow arrow). The number of aerosol particles diffused into the plastic case was measured with a particle counter (red arrow).

Simulated droplet and aerosol replication models.

(A) A sprayer was installed in the mouth of the head model (yellow arrow) and ink was sprayed. The paper onto which the ink was sprayed was imaged, and the number of pixels that became black after binarization was measured. (B) The airway management training model was placed inside the plastic case and the smoke from an e-cigarette was sprayed through a tube from outside the plastic case (yellow arrow). The number of aerosol particles diffused into the plastic case was measured with a particle counter (red arrow).

Aerosol simulation model

Aerosols dispersed from patients’ oral and nasal cavities were simulated by e-cigarette (FLEVO; GIEX, Tokyo, Japan) smoke. The e-cigarette was sprayed from the pulmonary side of an airway management training model (AirSim Advance Bronchi X; TruCorp., Lurgan, UK) so that cigarette smoke was only disseminated from the oral and nasal cavities. The e-cigarette was connected to a pump controlled by a computer to control the duration of the e-cigarette spray. The e-cigarette released smoke for 0.5 seconds in order to generate a similar number of aerosols as discharged in one cough [12, 17], and the number of e-cigarette smoke particles were similar to that discharged with a cough. The airway management training model was placed inside a plastic case in order to provide a stable environment. A particle counter (MET ONE HHPC 6+; Beckman Coulter, Brea, CA) was used to measure aerosols emitted. The particle counter was set to measure the number of particles 0.3–1.0 μm in size for 120 seconds with a sampling interval of 1 second. The total number of particles was defined as the total number of particles for 120 seconds at the time of evaluation minus the total number of particles for 120 seconds under normal conditions before evaluation. This calculation was performed in order to eliminate the influence of the number of particles present under normal conditions. The number of particles was measured five times under identical conditions, and the results were compared under varying conditions of wearing protective equipment and suction conditions as in the droplet experiment. For conditions with suction, suction was applied from the suction port at a pressure of -40 kPa and a flow rate of 40 L/min (Fig 3B).

Evaluation of the reduction of droplets dispersed through the endoscope

We created two simulation models as given below. Simulation model of the body fluids dispersed during removal of a treatment device. First, an instrument sleeve was placed on the procedure instrument. The instrument was inserted through the instrument channel, and the tip of the instrument was extended by several centimeters. The instrument sleeve was fixed to the endoscope. The tip of the endoscope was dipped into black ink and the instrument was then removed, following which the sleeve was checked for the presence of black ink adhering to its inner surface. Simulation model of body fluids discharged from the suction button through the endoscope. First, the control section cover was attached to the endoscope. The endoscope was connected to an aspirator, which was set to a pressure of −66 kPa and a flow rate of 40 L/min. The tip of the endoscope was dipped into black ink and the suction button was pressed through the control section cover once every second for a total of 30 times. Thereafter, the adhesion of black ink inside the operator’s cover was checked. As no human or animal subjects were used in this study, ethical review board approval and study participation consent were not applicable. The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details.

Statistical analysis

Each condition was compared to the control and conditions with suction were compared to those without suction with respect to the average number of black pixels and aerosols, respectively. Statistical analyses were conducted using Minitab statistical software version 20 (Minitab LLC, State College, PA, USA) to assess differences in these comparisons. Nonparametric statistical techniques (Mann-Whitney U tests) were applied owing to the small sample size.

Results

Evaluation of the reduction of droplets and aerosols dispersed from patient model

No significant difference was observed in the number of black pixels (representing patient droplets) for device configuration No. 1 and No.2 (wearing a mask without a rubber slit) and those of the control. However, compared to the control, decreases of more than 95% and equal to 100% were observed for device configuration No. 3 and No.4 (wearing a mask with a rubber slit) and device configuration No. 5 and No.6 (wearing a mask with a rubber slit and using an endoscope with an insertion sleeve), respectively. No significant difference in the data between using devices with and without suction was observed (Fig 4A) (Table 1).
Fig 4

Results of the droplet and aerosol simulations.

Experimental evaluation was performed under the following device configurations: control—no mask; No. 1—wearing a mask without a rubber slit (for surgery) without suction; No. 2—wearing a mask without a rubber slit (for surgery) with suction; No. 3—wearing a mask with a rubber slit (for outpatients) without suction; No. 4—wearing a mask with a rubber slit (for outpatients) with suction; No. 5—wearing a mask with a rubber slit (for outpatients) and using an insertion sleeve for the endoscope without suction; No. 6—wearing a mask with a rubber slit (for outpatients) and using an insertion sleeve for the endoscope with suction. (A) The average number of black pixels, representing droplets (n = 5). (B) The average number of aerosols (n = 5). * P<0.05 vs. control. # P<0.05 between devices used with suction and those used without suction. Statistical analysis was performed using the Mann-Whitney U test.

Table 1

Results of the droplet and aerosol simulations.

No. Mask Rubber slit Sleeve Suction Droplet (n = 5)
Average number of pixels (95% CI) SD Vs. control With suction vs. without suction
Average difference (95% CI) % Decrease P value Effect size Average difference (95% CI) % Decrease P value Effect size
Control ----760761 (688089,833433)58528
1 +---701091 (542863,859319)127432-59670 (-220878, 101538)-7.840.400.60136101 (-26984, 299186)19.410.14-1.35
2 +--+837192 (759790,914595)6233776431 (-13991, 166854)10.040.09-1.26
3 ++--33965 (28540, 39389)4369-726796 (-799670, -653923)-95.53<0.0517.512778 (-4221, 9776)8.170.83-0.59
4 ++-+36742 (30570,42915)4971-724019 (-796952, -651085)-95.17<0.0517.43
5 +++-0N.A.-760761-100<0.0518.3800N.A.N.A.
6 ++++0N.A.-760761-100<0.0518.38
No. Mask Rubber slit Sleeve Suction Aerosol (n = 5)
Average number of aerosols (95% CI) SD Vs. control With suction vs. without suction
Average difference (95% CI) % Decrease P value Effect size Average difference (95% CI) % Decrease P value Effect size
Control ----456267 (422998, 489535)26793
1 +---327019 (308714, 345324)14742-129248 (-162713, -95782)-28.32<0.055.97-318982 (-337906, -300058)-97.54<0.0525.2
2 +--+8037 (-4557, 20631)10143-448230 (-481165, -415295)-98.23<0.0522.12
3 ++--262385 (180921, 343849)65608-193882 (-275352, -112411)-42.49<0.053.86-262183 (-343647, -180718)-99.92<0.055.65
4 ++-+202 (-142, 547)278-456064 (-489335, -422794)-99.95<0.0524.07
5 +++-167871 (141787, 193954)21007-288396 (-324400, -252392)-63.20<0.0511.97-167685 (-193769, -141601)-99.89<0.0511.28
6 ++++185 (-48, 418)188-456081 s(-489351, -422812)-99.95<0.0524.07

Under each condition, the average number of black pixels/aerosols, the percent reduction compared with that of the control group, the P value and effect size compared with those of the control group (Mann-Whitney U test), and the comparison of P values and effect sizes between devices used with and without suction (Mann-Whitney U test) are indicated.

Results of the droplet and aerosol simulations.

Experimental evaluation was performed under the following device configurations: control—no mask; No. 1—wearing a mask without a rubber slit (for surgery) without suction; No. 2—wearing a mask without a rubber slit (for surgery) with suction; No. 3—wearing a mask with a rubber slit (for outpatients) without suction; No. 4—wearing a mask with a rubber slit (for outpatients) with suction; No. 5—wearing a mask with a rubber slit (for outpatients) and using an insertion sleeve for the endoscope without suction; No. 6—wearing a mask with a rubber slit (for outpatients) and using an insertion sleeve for the endoscope with suction. (A) The average number of black pixels, representing droplets (n = 5). (B) The average number of aerosols (n = 5). * P<0.05 vs. control. # P<0.05 between devices used with suction and those used without suction. Statistical analysis was performed using the Mann-Whitney U test. Under each condition, the average number of black pixels/aerosols, the percent reduction compared with that of the control group, the P value and effect size compared with those of the control group (Mann-Whitney U test), and the comparison of P values and effect sizes between devices used with and without suction (Mann-Whitney U test) are indicated. There was a reduction in the number of aerosols in the absence of suction relative to the control; aerosols were reduced by 28% in No. 1 (wearing a mask without a rubber slit), by 42% in No. 3 (wearing a mask with a rubber slit), and by 63% or more in No. 5 (wearing a mask with a rubber slit and using an endoscope with an insertion sleeve). When suction was applied, there was a significant decrease of 98% or more in No. 2 (wearing a mask without a rubber slit), and 99% or more in No. 4 (wearing a mask with a rubber slit) and No. 6 (wearing a mask with a rubber slit and using an endoscope with an insertion sleeve) compared to that of the control. In addition, there was a significant difference in the data between the conditions with and without suction, indicating that the reduction was more pronounced when suction was present (Fig 4B) (Table 1).

Evaluation of reduction of droplets dispersed through an endoscope

Simulation model of the body fluids dispersed during removal of a treatment device

The ink was confirmed to adhere to the inner surface of the instrument sleeve (Fig 5A).
Fig 5

Evaluation of instrument sleeve and control section cover.

(A) Ink that is released when the instrument is removed from the instrument channel of the endoscope adheres to the inside of the instrument sleeve (yellow arrow). An enlarged view of the adhered area is shown (yellow box). B: Ink released when pressing the suction button on the endoscope control unit adheres to the inside of the control section cover (yellow arrow). An enlarged view of the adhered area is shown (yellow box).

Evaluation of instrument sleeve and control section cover.

(A) Ink that is released when the instrument is removed from the instrument channel of the endoscope adheres to the inside of the instrument sleeve (yellow arrow). An enlarged view of the adhered area is shown (yellow box). B: Ink released when pressing the suction button on the endoscope control unit adheres to the inside of the control section cover (yellow arrow). An enlarged view of the adhered area is shown (yellow box).

Simulation model of body fluid discharged from the suction button through the endoscope

The ink was confirmed to adhere to the inner surface of the control section cover (Fig 5B).

Discussion

In otorhinolaryngology practice, several methods of shielding patients or surgeons during endoscopic examination and treatment have been reported [1, 18–24]. For example, Farneti et al. created the shielded ear, nose, and throat (ENT) headlights and protective shields that could be fitted to examination chairs for outpatient visits in an ENT setting [20]. Viera-Artiles et al., using a 3D printer, developed a mask that could be attached to the nose to eliminate aerosols during endoscopic nasal surgery [22]. The device we developed in this study is intended for disposable use. Protective equipment should be disposable because reusable products require cleaning and disinfection. This device is premised on the use of PPE for normal medical examination and surgery. Based on the results of the desk study, we will discuss the use and effects of the device in various situations in otorhinolaryngology. First, we will consider its use in the operating room, where aerosols are expected to be generated during many procedures. During surgery, there are many situations in which endoscopes and debriders are inserted into the patient’s nasal cavity simultaneously, and operability is the most important factor. The mask we developed has an opening for the insertion of an endoscope, which allows endoscopes to be operated in the same way as in normal medical treatment. In addition, by connecting the mask to an aspirator, we were able to reduce aerosols by as much as 98%. However, it is difficult to protect against droplets because the endoscope insertion port is open, but it is unlikely that droplets caused by coughing will spread when patients are under general anesthesia during surgery. In outpatient clinics where patients often cough, a mask with a rubber slit reduced droplets by more than 95%. In particular, connecting the mask to a suction device reduced aerosols by more than 99%. Although a 42% reduction in aerosols was achieved without suction, suction is considered preferable in view of its high effectiveness in reducing aerosols. When inserting an endoscope, diffusion of droplets and aerosols can be suppressed by more than 99% by fitting the endoscope with an insertion sleeve. Furthermore, the sleeve is expected to prevent contact with any body fluids of patients that adhere to the inserted part of the endoscope after the examination. When an endoscope is used for treatment, it was shown that the attachment of the instrument sleeve to the instrument in advance prevents contact with and diffusion of body fluid dispersed by removal of the instrument. In addition, our results indicate that we can expect that leakage of droplets of fluid from the suction button can be reduced by attaching the control section cover. There are, however, some limitations to this device and our experiments. In this experiment, we simulated aerosols using e-cigarette smoke and droplets with black ink; however, details regarding the generation of aerosols and droplets and the route of infection in actual clinical use are unknown. This device aims to reduce the risk of transmission of infectious diseases but does not guarantee infection prevention. We plan to verify the effectiveness of this device in clinical practice. In addition, since the mask is worn by the patient, we plan to assess the patient’s normal breathing and level of discomfort when wearing the mask. It is expected that this device may be used not only in otorhinolaryngology but also during endoscopic procedures in other fields, such as gastroenterology and respiratory medicine. As the importance of infection prevention measures for medical personnel has increased with the outbreak of COVID-19, we expect that this device may contribute to the prevention of infection in many endoscopic fields.

Conclusions

In this study, we developed a device for infection control in collaboration with a gastrointestinal endoscopist and Olympus Medical Systems Corporation. The device was found to be effective in reducing the spread of droplets and aerosols. Although there are some limitations related to the theoretical nature of this study, we expect this device to be effective in reducing droplet and aerosol diffusion during outpatient and surgical procedures in otorhinolaryngology. 28 Feb 2022
PONE-D-21-36009
Development of protective equipment for endoscopic treatment and surgery in otorhinolaryngology
PLOS ONE Dear Dr. Matsuwaki, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please pay attention to more clearer figures and results Please submit your revised manuscript by Apr 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Claudio Andaloro Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Competing Interests section: I have read the journal's policy and the authors of this manuscript have the following competing interests: This research and development endeavor was conducted in collaboration with Olympus Medical Systems Corporation and a gastrointestinal endoscopist (Dr. Daisuke Kikuchi). Matsuwaki Clinic Shinagawa and Olympus Medical Systems Corporation have concluded an advisory agreement regarding this development. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 3. We note that Figure 2 includes an image of a participant in the study. As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study is indeed essential and relevant to be carried out. The paper was well written with acceptable figures. My only concern is that the actual p values were not stated, either in the text or figure legends. Additionally, since the sample size was small, including an effect size analysis is beneficial to support the p values. Reviewer #2: This manuscript is the study to validate the protective equipment for endoscopic 'treatment and surgery'. The simulated situations are droplet spread and aerosal simulation model. The protective equipment are: suction-capable mask, sleeves and cover for suction. The main result is reduction of droplet and aerosal diffusion from there protective equipment. There are some issues needed to be elucidated. 1) The main result has been displayed in two bar graphs but not in the table. The actual parameter/value will be easier and clearer for verification of 95% Confidence interval and p-value. 2) The author mention about the number of test as 'five times' but these values have not been shown in the figures. 3) The title mention about 'endoscopic treatment and surgery' but the testing situation was conducted by 'flexible endoscope' which unusual for 'surgery' in ENT. 4) The displayed pictures are difficult for reader to follow the method. More simplified, eg cartoon/drawing, should be done for clarification. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
19 Apr 2022 Response to Reviewers’ Comments Reviewer #1: This study is indeed essential and relevant to be carried out. The paper was well written with acceptable figures. My only concern is that the actual p values were not stated, either in the text or figure legends. Additionally, since the sample size was small, including an effect size analysis is beneficial to support the p values. Reply: Thank you for your encouraging comment. I have added p-values to the legend of Fig.4 and p-values and the effect sizes in Table 1 in the revised manuscript (lines 243-256). Reviewer #2: This manuscript is the study to validate the protective equipment for endoscopic 'treatment and surgery'. The simulated situations are droplet spread and aerosol simulation model. The protective equipments are: suction-capable mask, sleeves and cover for suction. The main result is reduction of droplet and aerosol diffusion from there protective equipment. There are some issues needed to be elucidated. 1) The main result has been displayed in two bar graphs but not in the table. The actual parameter/value will be easier and clearer for verification of 95% Confidence interval and p-value. Reply: Thank you for your comment. I have added p-values to the legend of Fig.4. I have also added 95% confidence interval values and p-values as well as the effect sizes to Table 1 in the revised manuscript (lines 243-256) 2) The author mention about the number of test as 'five times' but these values have not been shown in the figures. Reply: Thank you for pointing this out. I have indicated the number of tests as “n=5” in the revised version of Fig. 4 and in Table 1 (lines 243-245). I have also added it to the legend of Fig. 4 (lines 246-256). 3) The title mention about 'endoscopic treatment and surgery' but the testing situation was conducted by 'flexible endoscope' which unusual for 'surgery' in ENT. Reply: Thank you for your constructive feedback. During surgery, a rigid scope is used. Since the patient is anesthetized during surgery, the risk of splashing due to the patient sneezing, etc., is low. Therefore, the insertion sleeve need not be attached to the rigid scope or treatment tool, and only the surgical mask should be used. During outpatient treatments, in addition to the outpatient mask, the insertion sleeve is attached to the flexible endoscope or the rigid endoscope and used in combination to reduce the risk of splashing. In the experiment, the surgical scene (Nos. 1 and 2 in Fig. 4) and the outpatient scene (Nos. 3-6 in Fig. 4) are shown. The flexible endoscope is used only for evaluation in outpatient situations. This content is described in the Experiments section on (lines 145-156). 4) The displayed pictures are difficult for reader to follow the method. More simplified, eg cartoon/drawing, should be done for clarification. Reply: Thank you for this valuable suggestion. Cartoon drawings have been added to Fig. 2 to help the readers understand the outpatient and surgical procedures. I hope that this will also help address the query raised in Comment 3. I also added a cartoon drawing to Fig. 5 to clearly present the experimental procedures. Submitted filename: Response to reviewers.docx Click here for additional data file. 12 May 2022 Development of protective equipment for endoscopic treatment and surgery in otorhinolaryngology PONE-D-21-36009R1 Dear Dr. Matsuwaki, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Claudio Andaloro Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All my concerns have been satisfactorily addressed by the authors and the paper looks much better now. As such, this paper can be accepted for publication. Reviewer #2: The manuscript has been revised according to the reviewer comments. The comments have been reposed clearly point-by-point. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Pongsakorn Tantilipikorn MD PhD 3 Jun 2022 PONE-D-21-36009R1 Development of protective equipment for endoscopic treatment and surgery in otorhinolaryngology Dear Dr. Matsuwaki: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Claudio Andaloro Academic Editor PLOS ONE
  23 in total

1.  Exhaled droplets due to talking and coughing.

Authors:  Xiaojian Xie; Yuguo Li; Hequan Sun; Li Liu
Journal:  J R Soc Interface       Date:  2009-10-07       Impact factor: 4.118

2.  Application of a Modified Endoscopy Face Mask for Flexible Laryngoscopy During the COVID-19 Pandemic.

Authors:  Vishal Narwani; Nikita Kohli; Michael Z Lerner
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-19       Impact factor: 3.497

3.  A Closed Chamber ENT Examination Unit for Aerosol-Generating Endoscopic Examinations of COVID-19 Patients.

Authors:  İbrahim Sayin; İbrahim Devecioğlu; Zahide Mine Yazıcı
Journal:  Ear Nose Throat J       Date:  2020-06-11       Impact factor: 1.697

Review 4.  High-Risk Aerosol-Generating Procedures in COVID-19: Respiratory Protective Equipment Considerations.

Authors:  Brittany E Howard
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-12       Impact factor: 3.497

5.  Patient-Worn Enhanced Protection Face Shield for Flexible Endoscopy.

Authors:  Jack B Anon; Carter Denne; Darcy Rees
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-09       Impact factor: 3.497

6.  It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19).

Authors:  Lidia Morawska; Donald K Milton
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 7.  Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology - head and neck surgery during the COVID-19 pandemic.

Authors:  Andrew Thamboo; Jane Lea; Doron D Sommer; Leigh Sowerby; Arman Abdalkhani; Christopher Diamond; Jennifer Ham; Austin Heffernan; M Cai Long; Jobanjit Phulka; Yu Qi Wu; Phillip Yeung; Marc Lammers
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-05-06

Review 8.  Aerosol-generating otolaryngology procedures and the need for enhanced PPE during the COVID-19 pandemic: a literature review.

Authors:  Paul Mick; Russell Murphy
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-05-11

Review 9.  AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.

Authors:  Shahnaz Sultan; Joseph K Lim; Osama Altayar; Perica Davitkov; Joseph D Feuerstein; Shazia M Siddique; Yngve Falck-Ytter; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2020-04-01       Impact factor: 22.682

10.  Suction mitigation of airborne particulate generated during sinonasal drilling and cautery.

Authors:  Alan D Workman; Roy Xiao; Allen Feng; Shekhar K Gadkaree; Alicia M Quesnel; Benjamin S Bleier; George A Scangas
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-15       Impact factor: 5.426

View more
  1 in total

1.  Shielding device for endoscopic procedures during lower gastrointestinal endoscopy.

Authors:  Daisuke Kikuchi; Daiki Ariyoshi; Yugo Suzuki; Yorinari Ochiai; Hiroyuki Odagiri; Junnosuke Hayasaka; Masami Tanaka; Tetsuya Morishima; Keita Kimura; Hiroshi Ezawa; Sanae Nakagawa; Risa Iwamoto; Yoshinori Matsuwaki; Shu Hoteya
Journal:  DEN open       Date:  2022-10-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.